{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:50:25Z","timestamp":1772895025571,"version":"3.50.1"},"reference-count":98,"publisher":"Japanese Society of Internal Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2005]]},"DOI":"10.2169\/internalmedicine.44.179","type":"journal-article","created":{"date-parts":[[2005,4,4]],"date-time":"2005-04-04T06:05:45Z","timestamp":1112594745000},"page":"179-187","source":"Crossref","is-referenced-by-count":37,"title":["Chronic Kidney Disease as a Metabolic Syndrome with Malnutrition-Need for Strict Control of Risk Factors"],"prefix":"10.2169","volume":"44","author":[{"given":"Tetsuo","family":"SHOJI","sequence":"first","affiliation":[{"name":"Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"NISHIZAWA","sequence":"additional","affiliation":[{"name":"Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Lindner A, Charra B, Sherrard DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med <b>290<\/b>: 697-701, 1974.","DOI":"10.1056\/NEJM197403282901301"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Levey AS, Beto JA, Coronado BE, et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis <b>32<\/b>: 853-906, 1998.","DOI":"10.1016\/S0272-6386(98)70145-3"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Sarnak MJ, Levey AS. Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis <b>35<\/b>: S117-S131, 2000.","DOI":"10.1016\/S0272-6386(00)70239-3"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Kawagishi T, Nishizawa Y, Konishi T, et al. High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia. Kidney Int <b>48<\/b>: 820-826, 1995.","DOI":"10.1038\/ki.1995.356"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Shoji T, Kawagishi T, Emoto M, et al. Additive impacts of diabetes and renal failure on carotid atherosclerosis. Atherosclerosis <b>153<\/b>: 257-258, 2000.","DOI":"10.1016\/S0021-9150(00)00529-3"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00372.x"},{"issue":"11","key":"7","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.2169\/internalmedicine.42.1095","volume":"42","author":"NAKASHIMA A","year":"2003","ISSN":"https:\/\/id.crossref.org\/issn\/0918-2918","issn-type":"print"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) London GM, Marchais SJ, Safar ME, et al. Aortic and large artery compliance in end-stage renal failure. Kidney Int <b>37<\/b>: 137-142, 1990.","DOI":"10.1038\/ki.1990.19"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Shoji T, Nishizawa Y, Kawagishi T, et al. Intermediate-density lipoprotein as an independent risk factor for aortic atherosclerosis in hemodialysis patients. J Am Soc Nephrol <b>9<\/b>: 1277-1284, 1998.","DOI":"10.1681\/ASN.V971277"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00468.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Benedetto FA, Mallamaci F, Tripepi G, Zoccali C. Prognostic value of ultrasonographic measurement of carotid intima media thickness in dialysis patients. J Am Soc Nephrol <b>12<\/b>: 2458-2464, 2001.","DOI":"10.1681\/ASN.V12112458"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2003.50025"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00205.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation <b>99<\/b>: 2434-2439, 1999.","DOI":"10.1161\/01.CIR.99.18.2434"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Shoji T, Emoto M, Shinohara K, et al. Diabetes mellitus, aortic stiffness, and cardiovascular mortality in end-stage renal disease. J Am Soc Nephrol <b>12<\/b>: 2117-2124, 2001.","DOI":"10.1681\/ASN.V12102117"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.0590051834.x"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.27.471"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.157.13.1413"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Samuelsson O. Proteinuria as a prognostic factor during long term hypertensive care. Drugs <b>35<\/b> Suppl 5: 48-54, 1988.","DOI":"10.2165\/00003495-198800355-00008"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Hillege HL, Girbes AR, de Kam PJ, et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation <b>102<\/b>: 203-210, 2000.","DOI":"10.1161\/01.CIR.102.2.203"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.32799"},{"key":"22","unstructured":"22) Kidney Disease Outcomes Quality Initiative (K\/DOQI) Group. K\/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease. Am J Kidney Dis <b>41<\/b>: I-IV, S1-S91, 2003."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Kidney Disease Outcomes Quality Initiative (K\/DOQI). K\/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis <b>43<\/b>: S1-S290, 2004.","DOI":"10.1053\/j.ajkd.2004.03.003"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) IV. NKF-K\/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000. Am J Kidney Dis <b>37<\/b>: S182-S238, 2001.","DOI":"10.1016\/S0272-6386(01)70008-X"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000095676.90936.80"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Shoji T, Ishimura E, Inaba M, Tabata T, Nishizawa Y. Atherogenic lipoproteins in end-stage renal disease. Am J Kidney Dis <b>38<\/b>: S30-S33, 2001.","DOI":"10.1053\/ajkd.2001.27393"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Shoji T, Nishizawa Y, Kawagishi T, et al. Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysis. Atherosclerosis <b>131<\/b>: 229-236, 1997.","DOI":"10.1016\/S0021-9150(97)00054-3"},{"issue":"6","key":"28","doi-asserted-by":"crossref","first-page":"305","DOI":"10.5551\/jat.9.305","volume":"9","author":"KIMOTO E","year":"2002","ISSN":"https:\/\/id.crossref.org\/issn\/1340-3478","issn-type":"print"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Mordasini R, Frey F, Flury W, Klose G, Greten H. Selective deficiency of hepatic triglyceride lipase in uremic patients. N Engl J Med <b>297<\/b>: 1362-1366, 1977.","DOI":"10.1056\/NEJM197712222972502"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Shoji T, Nishizawa Y, Nishitani H, Yamakawa M, Morii H. Impaired metabolism of high density lipoprotein in uremic patients. Kidney Int <b>41<\/b>: 1653-1661, 1992.","DOI":"10.1038\/ki.1992.238"},{"key":"31","unstructured":"31) Ibels SL, Reardon MF, Nestel PJ. Plasma post-heparin lipolytic activity and triglyceride clearance in uremic and hemodialysis patients and renal allograft recipients. J Lab Clin Med <b>87<\/b>: 648-658, 1976."},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Nishizawa Y, Shoji T, Nishitani H, et al. Hypertriglyceridemia and lowered apolipoprotein C-II\/C-III ratio in uremia: effect of a fibric acid, clinofibrate. Kidney Int <b>44<\/b>: 1352-1359, 1993.","DOI":"10.1038\/ki.1993.388"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Hirano T, Oi K, Sakai S, Kashiwazaki K, Adachi M, Yoshino G. High prevalence of small dense LDL in diabetic nephropathy is not directly associated with kidney damage: a possible role of postprandial lipemia. Atherosclerosis <b>141<\/b>: 77-85, 1998.","DOI":"10.1016\/S0021-9150(98)00150-6"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Oi K, Hirano T, Sakai S, Kawaguchi Y, Hosoya T. Role of hepatic lipase in intermediate-density lipoprotein and small, dense low-density lipoprotein formation in hemodialysis patients. Kidney Int Suppl <b>71<\/b>: S227-228, 1999.","DOI":"10.1046\/j.1523-1755.1999.07159.x"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Bagdade JD, Albers JJ. Plasma high-density lipoprotein concentrations in chronic-hemodialysis and renal-transplant patients. N Engl J Med <b>296<\/b>: 1436-1439, 1977.","DOI":"10.1056\/NEJM197706232962504"},{"key":"36","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000117286.85443.7D"},{"key":"37","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000046962.43220.8A"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Nishizawa Y, Shoji T, Kakiya R, et al. Non-high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal disease. Kidney Int Suppl: S117-S120, 2003 (Erratum in: Kidney Int Suppl <b>63<\/b>: 2345-2346, 2003).","DOI":"10.1046\/j.1523-1755.63.s84.30.x"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Shoji T, Kimoto E, Shinohara K, et al. The association of antibodies against oxidized low-density lipoprotein with atherosclerosis in hemodialysis patients. Kidney Int Suppl: S128-130, 2003.","DOI":"10.1046\/j.1523-1755.63.s84.37.x"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Fukumoto M, Shoji T, Emoto M, Kawagishi T, Okuno Y, Nishizawa Y. Antibodies against oxidized LDL and carotid artery intima-media thickness in a healthy population. Arterioscler Thromb Vasc Biol <b>20<\/b>: 703-707, 2000.","DOI":"10.1161\/01.ATV.20.3.703"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Koch M, Kutkuhn B, Trenkwalder E, et al. Apolipoprotein B, fibrinogen, HDL cholesterol, and apolipoprotein(a) phenotypes predict coronary artery disease in hemodialysis patients. J Am Soc Nephrol <b>8<\/b>: 1889-1898, 1997.","DOI":"10.1681\/ASN.V8121889"},{"key":"42","unstructured":"42) Japanese Society for Dialysis Therapy. An overview of regular dialysis treatment in Japan (as of Dec 31, 1998): 622-624."},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Degoulet P, Legrain M, Reach I, et al. Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study. Nephron <b>31<\/b>: 103-110, 1982.","DOI":"10.1159\/000182627"},{"key":"44","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00324.x"},{"key":"45","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.4.451"},{"key":"46","unstructured":"46) Kaizu Y, Tsunega Y, Yoneyama T, et al. Overweight as another nutritional risk factor for the long-term survival of non-diabetic hemodialysis patients. Clin Nephrol <b>50<\/b>: 44-50, 1998."},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Johansen KL, Young B, Kaysen GA, Chertow GM. Association of body size with outcomes among patients beginning dialysis. Am J Clin Nutr <b>80<\/b>: 324-332, 2004.","DOI":"10.1093\/ajcn\/80.2.324"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Leavey SF, Strawderman RL, Jones CA, Port FK, Held PJ. Simple nutritional indicators as independent predictors of mortality in hemodialysis patients. Am J Kidney Dis <b>31<\/b>: 997-1006, 1998.","DOI":"10.1053\/ajkd.1998.v31.pm9631845"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Kato A, Odamaki M, Yamamoto T, et al. Influence of body composition on 5 year mortality in patients on regular haemodialysis. Nephrol Dial Transplant <b>18<\/b>: 333-340, 2003.","DOI":"10.1093\/ndt\/18.2.333"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Fleischmann E, Teal N, Dudley J, May W, Bower JD, Salahudeen AK. Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients. Kidney Int <b>55<\/b>: 1560-1567, 1999 (Erratum in: Kidney Int <b>57<\/b>: 760, 2000).","DOI":"10.1046\/j.1523-1755.1999.00389.x"},{"key":"51","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0800832"},{"key":"52","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.17.2641"},{"key":"53","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejcn.1601208"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Liu L, Bopp MM, Roberson PK, Sullivan DH. Undernutrition and risk of mortality in elderly patients within 1 year of hospital discharge. J Gerontol A Biol Sci Med Sci <b>57<\/b>: M741-746, 2002.","DOI":"10.1093\/gerona\/57.11.M741"},{"key":"55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2003.11.039"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Zager PG, Nikolic J, Brown RH, et al. &ldquo;U&rdquo; curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc. Kidney Int <b>54<\/b>: 561-569, 1998 (Erratum in: Kidney Int <b>54<\/b>: 1417, 1998).","DOI":"10.1046\/j.1523-1755.1998.00005.x"},{"key":"57","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00812.x"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) Bostom AG, Shemin D, Verhoef P, et al. Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study. Arterioscler Thromb Vasc Biol <b>17<\/b>: 2554-2558, 1997.","DOI":"10.1161\/01.ATV.17.11.2554"},{"key":"59","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00018.x"},{"key":"60","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.00273.x"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61) Panichi V, Maggiore U, Taccola D, et al. Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients. Nephrol Dial Transplant <b>19<\/b>: 1154-1160, 2004.","DOI":"10.1093\/ndt\/gfh052"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62) Panichi V, Migliori M, De Pietro S, et al. C-reactive protein and interleukin-6 levels are related to renal function in predialytic chronic renal failure. Nephron <b>91<\/b>: 594-600, 2002 (Erratum in: Nephron <b>92<\/b>: 498, 2002).","DOI":"10.1159\/000065018"},{"key":"63","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00504.x"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64) DeFronzo RA, Alvestrand A, Smith D, Hendler R, Hendler E, Wahren J. Insulin resistance in uremia. J Clin Invest <b>67<\/b>: 563-568, 1981.","DOI":"10.1172\/JCI110067"},{"key":"65","doi-asserted-by":"publisher","DOI":"10.1159\/000046098"},{"key":"66","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000019900.87535.43"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67) Morioka T, Emoto M, Tabata T, et al. Glycemic control is a predictor of survival for diabetic patients on hemodialysis. Diabetes Care <b>24<\/b>: 909-913, 2001.","DOI":"10.2337\/diacare.24.5.909"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68) Maggi E, Bellazzi R, Falaschi F, et al. Enhanced LDL oxidation in uremic patients: an additional mechanism for accelerated atherosclerosis? Kidney Int <b>45<\/b>: 876-883, 1994.","DOI":"10.1038\/ki.1994.115"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69) Maggi E, Bellazzi R, Gazo A, Seccia M, Bellomo G. Autoantibodies against oxidatively-modified LDL in uremic patients undergoing dialysis. Kidney Int <b>46<\/b>: 869-876, 1994.","DOI":"10.1038\/ki.1994.344"},{"key":"70","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00692.x"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71) Locatelli F, Pisoni RL, Combe C, et al. Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant <b>19<\/b>: 121-132, 2004 (Erratum in: Nephrol Dial Transplant <b>19<\/b>: 1666, 2004).","DOI":"10.1093\/ndt\/gfg458"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72) Held PJ, Port FK, Wolfe RA, et al. The dose of hemodialysis and patient mortality. Kidney Int <b>50<\/b>: 550-556, 1996.","DOI":"10.1038\/ki.1996.348"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73) Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis <b>31<\/b>: 607-617, 1998.","DOI":"10.1053\/ajkd.1998.v31.pm9531176"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74) Avram MM, Sreedhara R, Avram DK, Muchnick RA, Fein P. Enrollment parathyroid hormone level is a new marker of survival in hemodialysis and peritoneal dialysis therapy for uremia. Am J Kidney Dis <b>28<\/b>: 924-930, 1996.","DOI":"10.1016\/S0272-6386(96)90396-0"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75) Avram MM, Mittman N, Myint MM, Fein P. Importance of low serum intact parathyroid hormone as a predictor of mortality in hemodialysis and peritoneal dialysis patients: 14 years of prospective observation. Am J Kidney Dis <b>38<\/b>: 1351-1357, 2001.","DOI":"10.1053\/ajkd.2001.29254"},{"key":"76","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022536"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77) Shoji T, Shinohara K, Kimoto E, et al. Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population. Nephrol Dial Transplant <b>19<\/b>: 179-184, 2004.","DOI":"10.1093\/ndt\/gfg513"},{"key":"78","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000129337.50739.48"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79) Nishizawa Y, Shoji T, Ishimura E, Inaba M, Morii H. Paradox of risk factors for cardiovascular mortality in uremia: is a higher cholesterol level better for atherosclerosis in uremia? Am J Kidney Dis <b>38<\/b>: S4-S7, 2001.","DOI":"10.1053\/ajkd.2001.27380"},{"issue":"2","key":"80","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2169\/internalmedicine.38.202","volume":"38","author":"FUNAHASHI T","year":"1999","ISSN":"https:\/\/id.crossref.org\/issn\/0918-2918","issn-type":"print"},{"key":"81","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2004.09.012"},{"key":"82","doi-asserted-by":"publisher","DOI":"10.1007\/s001250050825"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83) Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med <b>333<\/b>: 1301-1307, 1995.","DOI":"10.1056\/NEJM199511163332001"},{"key":"84","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.19.2486"},{"key":"85","doi-asserted-by":"crossref","unstructured":"85) Nishizawa Y, Shoji T, Tabata T, Inoue T, Morii H. Effects of lipid-lowering drugs on intermediate-density lipoprotein in uremic patients. Kidney Int Suppl <b>71<\/b>: S134-136, 1999.","DOI":"10.1046\/j.1523-1755.1999.07133.x"},{"key":"86","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00862.x"},{"key":"87","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00109.x"},{"key":"88","unstructured":"88) Nishizawa Y, Shoji T, Emoto M, et al. Reduction of intermediate density lipoprotein by pravastatin in hemo- and peritoneal dialysis patients. Clin Nephrol <b>43<\/b>: 268-277, 1995."},{"key":"89","doi-asserted-by":"crossref","unstructured":"89) Nishikawa O, Mune M, Miyano M, et al. Effect of simvastatin on the lipid profile of hemodialysis patients. Kidney Int Suppl <b>71<\/b>: S219-S221, 1999.","DOI":"10.1046\/j.1523-1755.1999.07157.x"},{"key":"90","doi-asserted-by":"crossref","unstructured":"90) Ichihara A, Hayashi M, Ryuzaki M, Handa M, Furukawa T, Saruta T. Fluvastatin prevents development of arterial stiffness in haemodialysis patients with type 2 diabetes mellitus. Nephrol Dial Transplant <b>17<\/b>: 1513-1517, 2002.","DOI":"10.1093\/ndt\/17.8.1513"},{"key":"91","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2004.01.011"},{"key":"92","doi-asserted-by":"publisher","DOI":"10.1159\/000080241"},{"key":"93","doi-asserted-by":"crossref","unstructured":"93) Wanner C, Krane V, Ruf G, Marz W, Ritz E. Rationale and design of a trial improving outcome of type 2 diabetics on hemodialysis. Die Deutsche Diabetes Dialyse Studie Investigators. Kidney Int Suppl <b>71<\/b>: S222-226, 1999.","DOI":"10.1046\/j.1523-1755.1999.07158.x"},{"key":"94","doi-asserted-by":"crossref","unstructured":"94) Fellstrom BC, Holdaas H, Jardine AG. Why do we need a statin trial in hemodialysis patients? Kidney Int Suppl: S204-206, 2003.","DOI":"10.1046\/j.1523-1755.63.s84.10.x"},{"key":"95","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200215449"},{"key":"96","doi-asserted-by":"crossref","unstructured":"96) Mune M, Yukawa S, Kishino M, et al. Effect of vitamin E on lipid metabolism and atherosclerosis in ESRD patients. Kidney Int Suppl <b>71<\/b>: S126-129, 1999.","DOI":"10.1016\/S0085-2538(15)46619-0"},{"key":"97","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.0590051943.x"},{"key":"98","doi-asserted-by":"crossref","unstructured":"98) Miyazaki H, Matsuoka H, Itabe H, et al. Hemodialysis impairs endothelial function via oxidative stress: effects of vitamin E-coated dialyzer. Circulation <b>101<\/b>: 1002-1006, 2000.","DOI":"10.1161\/01.CIR.101.9.1002"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/44\/3\/44_3_179\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T23:55:32Z","timestamp":1625702132000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/44\/3\/44_3_179\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005]]},"references-count":98,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.44.179","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005]]}}}